IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, D.
Right arrow Articles by Niederkorn, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, D.
Right arrow Articles by Niederkorn, J. Y.

Investigative Ophthalmology & Visual Science, Vol 39, 1835-1846, Copyright © 1998 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Conditions affecting enhanced corneal allograft survival by oral immunization

D Ma, J Mellon and JY Niederkorn
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75235, USA.

PURPOSE: To determine the optimal conditions for enhancing corneal allograft survival by oral immunization with donor-specific alloantigens. METHODS: CB6F1 mice were orally immunized with various doses of C3H/Hej corneal epithelial and endothelial cells before receiving orthotopic C3H/Hej corneal allografts. Paraformaldehyde-fixed corneal cells were compared with viable corneal cells for their capacity to promote corneal allograft survival. The mucosal adjuvant, cholera toxin B (CTB), was examined for its capacity to enhance corneal graft survival when given separately or conjugated to corneal cells used for oral immunization. Oral immunization was also evaluated for its capacity to prevent immunologic rejection in three high-risk settings: preimmunized hosts, hosts with prevascularized graft beds, and grafts that contain donor-specific Langerhans' cells. RESULTS: Optimal graft survival occurred when 2 x 10(6) corneal cells were administered orally 10 days before orthotopic corneal transplantation. Paraformaldehyde-fixed corneal cells were as effective as viable cells in preventing corneal graft rejection. Cholera toxin B enhanced the efficacy of oral immunization when conjugated with the orally administered corneal cells but was ineffectual when administered separately. Oral immunization with donor corneal cells enhanced corneal graft survival in all three high-risk settings. CONCLUSIONS: Oral immunization with donor cells is an effective strategy for enhancing corneal graft survival and preventing graft rejection in high-risk settings. Graft enhancement is optimized when the orally administered cells are conjugated with CTB and administered before corneal transplantation. Because fixed cells retain their capacity to enhance corneal graft survival, it may be possible to store donor cells for long-term use in high-risk hosts.


This article has been cited by other articles:


Home page
 IOVSHome page
D. W. Clarke, H. Alizadeh, and J. Y. Niederkorn
Intracorneal Instillation of Latex Beads Induces Macrophage-Dependent Protection against Acanthamoeba Keratitis
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4917 - 4925.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Hegde, J. K. Mellon, S. L. Hargrave, and J. Y. Niederkorn
Effect of Alloantibodies on Corneal Allograft Survival
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1012 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Hegde and J. Y. Niederkorn
The Role of Cytotoxic T Lymphocytes in Corneal Allograft Rejection
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3341 - 3347.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Association for Research in Vision and Ophthalmology